Camille Sullivan

Camille Sullivan

Auto-generated profile, based on publicly available information

Camille Sullivan

Department of Biochemistry and Biophysics, Brandeis University and HHMI

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AGAndrew W. Glaser
Andrew W. Glaser
RPRicardo A. P. Pádua
Ricardo A. P. Pádua
AOAdedolapo M. Ojoawo
Adedolapo M. Ojoawo
CSCamille Sullivan
Camille Sullivan
DKDorothee Kern
Dorothee Kern
SH2 domains are critical mediators of cellular signaling, although the molecular mechanisms by which they bind their phosphopeptide ligands remain incompletely understood. We investigate the atomic mechanisms underlying both healthy regulation and dysregulation of the human protein tyrosine phosphatase SHP2, a key regulator of cellular signaling. While most pathogenic mutations cluster near the PTP/N-SH2 interface, the E139D and T42A mutations are located within the regulatory SH2 domains, and their mechanisms of dysregulation remain controversial. The T42A mutation in the N-SH2 domain paradoxically increases phosphotyrosine-peptide binding affinity despite disrupting the hydrogen bond of T42 to the phosphoryl group, a puzzling contradiction that remains unresolved. We find that the T42A mutation shifts the conformational ensemble of peptide-bound N-SH2 toward a zipped β-sheet state and suppresses millisecond conformational exchange, supporting a model in which enhanced stabilization of the zipped conformation contributes to hyperactivation. This conformational shift provides a structural rationale for the increased affinity of T42A and helps reconcile previously conflicting models of peptide-induced SHP2 activation. By integrating X-ray ensemble refinement with NMR relaxation, our work illustrates how complementary structural and dynamic approaches can uncover regulatory mechanisms in SHP2 and may inform broader principles of SH2-mediated phosphopeptide recognition.

2 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
EPE. Nicholas Petersen
E. Nicholas Petersen
EKEvelyn Keefer
Evelyn Keefer
HLHannes Nicholas Ludewig
Hannes Nicholas Ludewig
CSCamille Sullivan
Camille Sullivan
DKDorothee Kern
Dorothee Kern
MRMichael Rosbash
Michael Rosbash
Circadian timekeeping is orchestrated by multiple clock proteins, but mechanistic understanding is limited. AlphaFold predicts novel interactions between two helical domains of the Drosophila PERIOD (PER) protein and its major kinase Doubletime (DBT). These PER domains, SYQ and LT, are conserved with mammals and are predicted to interact identically with the DBT ortholog casein kinase 1 (CK1). SYQ and LT mutations designed to disrupt this interface result in severe period and temperature-sensitive fly phenotypes, and two LT mutations cause unprecedented free-running periods ≥ 44 hours and temperature-sensitive changes of ∼20 hours. Further characterization of a LT mutant strain shows a severe reduction in both PER phosphorylation and PER degradation. A human PER equivalent of the same LT mutation is a much less efficient in vitro substrate for CK1-mediated phosphorylation. These observations indicate that this conserved PER-DBT interaction is critical for PER phosphorylation, circadian timing and its enigmatic temperature compensation phenomena.

14 December 2025 in bioRxiv
Verified
Preprint
Open access
AGAndrew W. Glaser
Andrew W. Glaser
RPRicardo A. P. de Pádua
Ricardo A. P. de Pádua
AOAdedolapo M. Ojoawo
Adedolapo M. Ojoawo
CSCamille Sullivan
Camille Sullivan
DKDorothee Kern
Dorothee Kern
SH2 domains are critical mediators of cellular signaling, although the molecular mechanisms by which they bind their phosphopeptide ligands remain incompletely understood. We investigate the atomic mechanisms underlying both healthy regulation and dysregulation of the human protein tyrosine phosphatase SHP2, a key regulator of cellular signaling. While most pathogenic mutations cluster near the PTP/N-SH2 interface, the E139D and T42A mutations are located within the regulatory SH2 domains, and their mechanisms of dysregulation remain controversial. The T42A mutation in the N-SH2 domain paradoxically increases phosphotyrosine-peptide binding affinity despite disrupting the hydrogen bond of T42 to the phosphoryl group, a puzzling contradiction that remains unresolved. We find that the T42A mutation shifts the conformational ensemble of peptide-bound N-SH2 toward a zipped β-sheet state and suppresses millisecond conformational exchange, supporting a model in which enhanced stabilization of the zipped conformation contributes to hyperactivation. This conformational shift provides a structural rationale for the increased affinity of T42A and helps reconcile previously conflicting models of peptide-induced SHP2 activation. By integrating X-ray ensemble refinement with NMR relaxation, our work illustrates how complementary structural and dynamic approaches can uncover regulatory mechanisms in SHP2 and may inform broader principles of SH2-mediated phosphopeptide recognition. Significance Statement: Here, we characterize how two pathogenic SH2-domain mutations alter SHP2 regulation and lead to hyperactivation. We identify a previously unobserved apo conformation of the N-SH2 domain in which Tyr66 occludes the peptide-binding cleft, indicating that a conformational change is required for full binding of activating phosphopeptides. Our data suggest that the T42A mutation shifts the equilibrium toward a zipped central β-sheet state in the peptide-bound N-SH2 domain as the most likely model underlying the measured 10-fold increased binding affinity. These results help clarify the structural basis for SHP2 regulation and illustrate how conformational dynamics shape SH2-phosphopeptide recognition.